Study of SKB107 for advanced cancer with bone tumors
Part of Cancer clinical trials.
This trial tests a new drug, SKB107, for people whose advanced cancer has spread to the bones and standard treatments no longer work. The goal is to see if SKB107 can help shrink or slow these bone tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 to 75 years old
- Have advanced cancer that started elsewhere and spread to the bones, confirmed by biopsy or imaging
- Have tried or cannot have standard treatments
- Be well enough to get out of bed and care for yourself (ECOG score 0 or 1)
- Not have had certain other radiation or radionuclide treatments for bone tumors
- Must not have serious heart, liver, or other health problems that could interfere with the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, BPR-6023021, for people whose cancer has spread to the bones and who have run out of standard options. The goal is to see if it can help control the cancer and ease symptoms.
This trial tests a new drug called SKB518 for people with advanced solid tumors that have stopped responding to standard treatments or cannot receive them. The goal is to see if SKB518 can help shrink or control the tumor.
This study tests a new drug called SKB118 for advanced solid cancers (any cancer that has spread) that have not responded to standard treatments. The drug is designed to help the immune system fight cancer cells.
This trial tests a new drug called SKB571 for people with advanced lung cancer that has a specific change in the MET gene. The goal is to see if the drug can shrink tumors or stop them from growing.
This trial tests a new drug called SKB103 for people with advanced solid tumors that have not responded to standard treatments or who cannot tolerate them. The study aims to see if SKB103 is safe and effective.
This trial tests a new drug called SKB105 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and effective.
Hear when a new Metastatic Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.